406 filings
Page 3 of 21
EFFECT
ew3z2
13 Jun 23
Notice of effectiveness
12:15am
424B3
dfd3huwv8vntpd
12 Jun 23
Prospectus supplement
5:01pm
8-K
e5wtfokumkiqhjlo
9 Jun 23
Submission of Matters to a Vote of Security Holders
9:00am
CORRESP
8o37h
8 Jun 23
Correspondence with SEC
12:00am
UPLOAD
kbuea
7 Jun 23
Letter from SEC
12:00am
8-K/A
fxjrk8w2siw1q36q812r
2 Jun 23
Financial Statements and Exhibits
4:00pm
8-K
4xd0j
30 May 23
Entry into a Material Definitive Agreement
9:30am
8-K
8m5w020xnk
24 May 23
Regulation FD Disclosure
9:30am
8-K
r6325tzye t2oxby6ifc
23 May 23
Kineta to Present at Jefferies Healthcare Conference
9:30am
8-K
2setll5hrt
11 May 23
Kineta Reports First Quarter 2023 Financial Results and Provides Corporate Update
5:20pm
8-K
fhb98f63zetb svpulni
2 May 23
Entry into a Material Definitive Agreement
4:04pm
DEFA14A
8z5dgmptvy3r0nxr
28 Apr 23
Additional proxy soliciting materials
5:08pm
ARS
ffzks5i
28 Apr 23
Annual report to shareholders
5:07pm
8-K
pjutpp 5vg0azj
21 Apr 23
Kineta, Inc. Announces $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:16pm
424B5
phnt8u
21 Apr 23
Prospectus supplement for primary offering
5:14pm
424B5
o49c32f
20 Apr 23
Prospectus supplement for primary offering
8:09am
8-K
v03zd
17 Apr 23
Kineta Unveils New VISTA Biomarker Data and KVA12123 Phase 1/2 Clinical Trial Update at AACR Annual Meeting 2023
11:09am